Literature DB >> 31624011

HIV controllers: to treat or not to treat? Is that the right question?

Nicolas Noël1, Asier Saez-Cirion2, Véronique Avettand-Fenoël3, Faroudy Boufassa4, Olivier Lambotte5.   

Abstract

The term HIV controller refers to the small proportion of individuals infected with HIV who can spontaneously control viraemia to maintain very low viral loads. One major unresolved question is whether HIV controllers should receive antiretroviral therapy, given that international guidelines recommend treatment for all individuals who are infected with HIV. Differences in the definitions of a controller (in terms of the viral-load cutoff and the duration of viral control) and contrasting reports on CD4 T-cell decline, chronic immune activation, the cardiovascular risk, and loss of viral control in controllers have prevented the development of a consensus view.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31624011     DOI: 10.1016/S2352-3018(19)30264-4

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  6 in total

1.  Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.

Authors:  Nikolaus Jilg; Pilar Garcia-Broncano; Michael Peluso; Florencia P Segal; Ronald J Bosch; Carla Roberts-Toler; Samantha M Y Chen; Cornelius N Van Dam; Michael C Keefer; Daniel R Kuritzkes; Alan L Landay; Steven Deeks; Xu G Yu; Paul E Sax; Jonathan Z Li
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

2.  Approach to the management of paediatric HIV spontaneous controllers.

Authors:  Peter Zuidewind; Mark Cotton; Shaun Barnabas; Anita Janse Van Rensburg; Gert van Zyl; Carli Gordijn
Journal:  S Afr J Infect Dis       Date:  2022-06-30

Review 3.  Immunometabolism and HIV-1 pathogenesis: food for thought.

Authors:  Asier Sáez-Cirión; Irini Sereti
Journal:  Nat Rev Immunol       Date:  2020-08-06       Impact factor: 53.106

4.  Applicability of the long-term uncertainty in measurement (LTUM) method for analytical performance assessment in clinical cytometry laboratories.

Authors:  Louis-Thomas Dannus; Aurélien Mulliez; Marc Berger; Céline Bourgne; Richard Veyrat-Masson
Journal:  Cytometry B Clin Cytom       Date:  2021-12-16       Impact factor: 3.248

5.  Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort.

Authors:  Léo Plaçais; Faroudy Boufassa; Camille Lécuroux; Elise Gardiennet; Véronique Avettand-Fenoel; Asier Saez-Cirion; Olivier Lambotte; Nicolas Noël
Journal:  EClinicalMedicine       Date:  2021-06-18

6.  Elite and viremic HIV-1 controllers in West Africa.

Authors:  Jean Baptiste N'takpé; Delphine Gabillard; Raoul Moh; Elise Gardiennet; Thomas-d'Aquin Toni; Gérard M Kouame; Anani Badje; Arlette Emieme; Sophie Karcher; Jérome Le Carrou; Hervé Ménan; Christine Danel; Serge P Eholie; Christine Rouzioux; Xavier Anglaret; Olivier Lambotte
Journal:  AIDS       Date:  2022-01-01       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.